The EPSRC and MRC Systems Approaches to Biomedical Science CDT is an innovative 4-year D.Phil. programme in which every student works in collaboration with industry, conducting cutting edge research in:
- Computational and structural approaches underpinning drug and therapy discovery
- Data-driven drug discovery
- Physiological modelling underpinning drug discovery
We are an open collaboration between Oxford and 20 partner organisations (currently AstraZeneca, Bruker, Diamond Light Source, DNA Worldwide, e-Therapeutics, Evotec, GE Healthcare, GlaxoSmithKline, Hoffmann La Roche, Oxford Drug Design (formerly InhibOx), Lilly UK, MedImmune, Moffitt Cancer Center, Novartis, Novo Nordisk, OMass, Pfizer, Sharp, Structural Genomics Consortium and UCB).
We encourage applications from students with a wide range of academic backgrounds, including Mathematics, Computing, Statistics, Chemistry, Biochemistry, Physics, Biology, Pharmacology and Engineering.
Fully funded studentships are available. Non-UK candidates are eligible for industrial funding held by the CDT which will be awarded competitively. This would cover full fees and a stipend for living expenses, and candidates will be considered automatically based on their application to the programme.
Non-UK candidates are encouraged to explore alternative funding options as well; there are a number of university scholarship opportunities you can be considered for separately if you apply to the programme by 19 January 2017, please see www.graduate.ox.ac.uk/fundingsearch for details.
Important information for EU students can be found at http://www.ox.ac.uk/students/oxford-and-the-eu.
Please explore the links on this website to find more information about the programme and the research training provided, as well as funding available and instructions on how to apply.
The Doctoral Training Centre is a member of the Graduate Academic Programme (GAP) and fully supports the teaching and training of graduate students across the University of Oxford.
Applications for entry in 2018-19 are currently closed. The programme may reopen to applications on 1 May 2018 if places are available. This also applies to applications for the GSK-Crick Chemical Biology Doctoral Programme.
Note: In Oxford, the degree qualification commonly referred to as a Doctorate of Philosophy or Ph.D. is known as a D.Phil.